Network toxicology identifies a mechanistic link between DEHP exposure and airway inflammation, suggesting new insights for asthma treatments.
Environmental plasticizers are increasingly implicated in asthma susceptibility, yet the mechanisms linking chemical exposure to airway inflammation remain poorly defined. Here we show that the plasticizer di(2-ethylhexyl) phthalate (DEHP) directly drives a neutrophil-dominant asthma phenotype through activation of IL-17-centered immune pathways. Integrative network toxicology identified IL-6 and IL-1β as central inflammatory nodes connecting DEHP exposure with Th17 differentiation and IL-17 signaling. Consistent with these predictions, inhalational DEHP exposure in mice induced airway hyperresponsiveness, mixed granulocytic airway inflammation, mucus hypersecretion, and elevated pulmonary IL-6, IL-1β, and IL-17A expression. Immune profiling revealed expansion of IL-17A-producing lymphocytes, including Th17 cells and type 3 innate lymphoid cells (ILC3s). Genetic ablation of IL-17A markedly attenuated airway hyperresponsiveness and neutrophilic inflammation following DEHP exposure. Together, these findings identify an IL-6/IL-1β-Linked Th17/ILC3 axis as a mechanistic link between environmental plasticizer exposure and non-type 2 asthma, providing a conceptual framework for pollutant-driven airway disease.
No takes yet. Share an insight, caveat, or question.
(RN) et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: